Abstract
AbstractAntibody-dependent enhancement (ADE) is suspected to influence dengue virus (DENV) infection, but the role ADE plays in vaccination strategies incorporating live attenuated virus components is less clear. Using a heterologous prime-boost strategy in rhesus macaques, we examine the effect of priming with DENV purified inactivated vaccines (PIVs) on a tetravalent live attenuated vaccine (LAV). Sera exhibited low-level neutralizing antibodies (NAb) post PIV priming, yet moderate to high in vitro ADE activity. Following LAV administration, the PIV primed groups exhibited DENV-2 LAV peak viremias up to 1,176-fold higher than the mock primed group, and peak viremia correlated with in vitro ADE. Furthermore, PIV primed groups had more balanced and higher DENV-1–4 NAb seroconversion and titers than the mock primed group following LAV administration. These results have implications for the development of effective DENV vaccine prime-boost strategies and for our understanding of the role played by ADE in modulating DENV replication.
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Infectious Diseases,Pharmacology,Immunology
Reference71 articles.
1. Gubler, D. J. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 11, 480–496 (1998).
2. Ho, T. S., Wang, S. M., Lin, Y. S. & Liu, C. C. Clinical and laboratory predictive markers for acute dengue infection. J. Biomed. Sci. 20, 75 (2013).
3. Lei, H. Y. et al. Immunopathogenesis of dengue virus infection. J. Biomed. Sci. 8, 377–388 (2001).
4. Rashmi, M. V. & Hamsaveena Haematological and biochemical markers as predictors of dengue infection. Malays. J. Pathol. 37, 247–251 (2015).
5. Wilder-Smith, A., Earnest, A. & Paton, N. I. Use of simple laboratory features to distinguish the early stage of severe acute respiratory syndrome from dengue fever. Clin. Infect. Dis. 39, 1818–1823 (2004).
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献